Welcome toGeniouskin
About Us
Geniouskin creates a living skin substitute using the patient’s own cells.
Geniouskin
By combining the three essential skin cell types, APSD is designed to restore complete, functional, and natural skin.
Watch the video learn more
Technology
Two steps. One cure.
Geniouskin’s approach begins with a small patient biopsy, from which skin cells are isolated and expanded within a proprietary biomimetic matrix. As a fully autologous therapy, it eliminates rejection risk.
The engineered graft is then applied directly to the wound, where it integrates naturally to restore full-thickness, functional, and pigmented skin in a single intervention.
This process is reinforced by Process AI and Clinical AI, enabling standardized production, cost efficiency, and advanced clinical decision support.
From bench to bedside
A clear path forward from research to market launch.
Pre-Clinical
Protocol validation, biomimetic matrix development, and pre-clinical efficacy and safety data.
FIH & Phase I
First-in-human studies focused on safety, proof of concept, and Process AI integration.
Phase II/III
Pivotal multi-center trials, health economics data, and reimbursement submissions.
Market Launch
Regulatory approval, commercial manufacturing, partner activation, and global expansion.
Our Team
A highly qualified team combining clinical, scientific, and business expertise.
Entrepreneur and business developer with a strong foundation in branding, communication, and growth strategy, Patrick Alexandre brings a multidisciplinary approach to building high-impact ventures. With experience spanning the U.S. (notably California’s West Coast) and Europe, he has contributed to the development and scaling of companies in the food industry, combining market positioning with operational expansion.
His background in the music industry sharpened his expertise in storytelling, artist positioning, and audience engagement—skills he later transposed into the art world, where he successfully developed and monetized portfolios for painters and photographers.
Patrick’s core strength lies in his ability to connect vision with execution: structuring brands, orchestrating strategic networks, and assembling the right stakeholders to accelerate growth. At Geniouskin, he leverages his deep understanding of branding, PR, and business development to position the company as a next-generation leader in regenerative medicine.
Plastic, Reconstructive and Aesthetic Surgery, Bordeaux University Hospital, France.
More than 12 years working on chronic wounds: Running at least 2 clinical studies per year.
Orthoplastic organization director: hundreds of cases treated per year.
Pre-clinical validation complete.
100% graft take rate, 3× faster healing, 12+ years of R&D, and a fully autologous technology with zero rejection risk.
patients worldwide with chronic wounds
annual global wound care market
recurrence rate with current treatments
graft take rate in pre-clinical models
